The Professional Counselor | Volume 12, Issue 2 117 References Abraham, O., Schleiden, L., &Albert, S. M. (2017). Over-the-counter medications containing diphenhydramine and doxylamine used by older adults to improve sleep. International Journal of Clinical Pharmacy, 39(4), 808–817. https://doi.org/10.1007/s11096-017-0467-x Agbabiaka, T. B., Wider, B., Watson, L. K., & Goodman, C. (2017). Concurrent use of prescription drugs and herbal medicinal products in older adults: A systematic review. Drugs & Aging, 34(12), 891–905. https://doi.org/10.1007/s40266-017-0501-7 Al-Attraqchi, O. H. A., Deb, P. K., &Al-Attraqchi, N. H. A. (2020). Review of the phytochemistry and pharmacological properties of valeriana officinalis. Current Traditional Medicine, 6(4), 260–277. https://doi.org/10.2174/2215083805666190314112755 American Association of Medical Colleges. (2019). Figure 18. Percentage of all active physicians by race/ethnicity, 2018 [Figure]. https://www.aamc.org/data-reports/workforce/interactive-data/figure-18-percentage-all-activephysicians-race/ethnicity-2018 American Counseling Association. (2014). ACA code of ethics. https://www.counseling.org/Resources/aca-code-ofethics.pdf American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596 Apaydin, E. A., Maher, A. R., Shanman, R., Booth, M. S., Miles, J. N. V., Sorbero, M. E., & Hempel, S. (2016). A systematic review of St. John’s wort for major depressive disorder. Systematic Reviews, 5(1), Article 148. https://doi.org/10.1186/s13643-016-0325-2 Balick, M. J., & Cox, P. A. (2021). Plants, people, and culture: The science of ethnobotany (2nd ed.). CRC Press. Barnes, J., Anderson, L. A., & Phillipson, J. D. (2001). St John’s wort (Hypericum perforatum L.): A review of its chemistry, pharmacology and clinical properties. Journal of Pharmacy and Pharmacology, 53(5), 583–600. https://doi.org/10.1211/0022357011775910 Bentley, K. J., & Walsh, J. (2013). The social worker and psychotropic medication: Toward effective collaboration with mental health clients, families, and providers (4th ed.). Brooks/Cole. Bhugra, D., & Bhui, K. (Eds.). (2018). Textbook of cultural psychiatry (2nd ed.). Cambridge University Press. Bockholdt, B., Klug, E., & Schneider, V. (2001). Suicide through doxylamine poisoning. Forensic Science International, 119(1), 138–140. https://doi.org/10.1016/S0379-0738(00)00393-5 Bonn-Miller, M. O., Loflin, M. J. E., Thomas, B. F., Marcu, J. P., Hyke, T., & Vandrey, R. (2017). Labeling accuracy of cannabidiol extracts sold online. JAMA, 318(17), 1708–1709. https://doi.org/10.1001/jama.2017.11909 Booker, A., Frommenwiler, D., Reich, E., Horsfield, S., & Heinrich, M. (2016). Adulteration and poor quality of Ginkgo biloba supplements. Journal of Herbal Medicine, 6(2), 79–87. https://doi.org/10.1016/j.hermed.2016.04.003 Borges, G., Aguilar-Gaxiola, S., Andrade, L., Benjet, C., Cia, A., Kessler, R. C., Orozco, R., Sampson, N., Stagnaro, J. C., Torres, Y., Viana, M. C., & Medina-Mora, M. E. (2020). Twelve-month mental health service use in six countries of the Americas: A regional report from the World Mental Health Surveys. Epidemiology and Psychiatric Sciences, 29, 1–15. https://doi.org/10.1017/S2045796019000477 Boudjemai, Y., Mbida, P., Potinet-Pagliaroli, V., Géffard, F., Leboucher, G., Brazier, J.-L., Allenet, B., & Charpiat, B. (2013). Patients’ knowledge about paracetamol (acetaminophen): A study in a French hospital emergency department. Annales Pharmaceutiques Françaises, 71(4), 260–267. https://doi.org/10.1016/j.pharma.2013.03.001 Boyer, E. W., & Shannon, M. (2005). The serotonin syndrome. The New England Journal of Medicine, 352(11), 1112– 1120. https://doi.org/10.1056/NEJMra041867 Brahmachari, G. (Ed.). (2018). Discovery and development of neuroprotective agents from natural products. Elsevier. https://doi.org/10.1016/B978-0-12-809593-5.12001-4 Brown, A. C. (2017). An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series. Food and Chemical Toxicology, 107 (Part A), 449–471. https://doi.org/10.1016/j.fct.2016.11.001 Brown, J. D., & Winterstein, A. G. (2019). Potential adverse drug events and drug–drug interactions with medical and consumer cannabidiol (CBD) use. Journal of Clinical Medicine, 8(7), 989. https://doi.org/10.3390/jcm8070989
RkJQdWJsaXNoZXIy NDU5MTM1